ACC.16 Evolocumab lowers LDL cholesterol significantly more than ezetimibe in statinintolerant patients

After 24 weeks patients with a history of musclerelated statin intolerance and high levels of lowdensity lipoprotein LDL cholesterol who received evolocumab had significant reductions in LDL cholesterol compared with patients who received ezetimibe. In add...